Lines, Christopher
Merck & Co., Inc., Rahway, NJ, USA (United States)
4 papers on CoChat
Most cited papers
- Verified
Cardiovascular Events Associated with Rofecoxib in a Colorectal Adenoma Chemoprevention Trial
Bresalier, R. S., Sandler, R. S., Quan, H., Bolognese, J. A., Oxenius, B., Horgan, K., Lines, C., Riddell, R., Morton, D., Lanas, A., et al. (2005) · New England Journal of Medicine
Inflammatory mediators and NSAID effectsAntiplatelet Therapy and Cardiovascular Diseases
Cited by 2,519
- Verified
Lack of Efficacy of the Substance P (Neurokinin1 Receptor) Antagonist Aprepitant in the Treatment of Major Depressive Disorder
Keller, M., Montgomery, S., Ball, W., Morrison, M., Snavely, D., Liu, G., Hargreaves, R., Hietala, J., Lines, C., Beebe, K., et al. (2006) · Biological Psychiatry
Treatment of Major DepressionTryptophan and brain disorders
Cited by 286
- Verified
Cognitive outcomes in trials of two BACE inhibitors in Alzheimer's disease
Wessels, A. M., Lines, C., Stern, R. A., Kost, J., Voss, T., Mozley, L. H., Furtek, C., Mukai, Y., Aisen, P. S., Cummings, J. L., et al. (2020) · Alzheimer's & Dementia
Alzheimer's disease research and treatmentsDementia and Cognitive Impairment Research
Cited by 86
- Verified
Further analyses of the safety of verubecestat in the phase 3 EPOCH trial of mild-to-moderate Alzheimer’s disease
Egan, M. F., Mukai, Y., Voss, T., Kost, J., Stone, J., Furtek, C., Mahoney, E., Cummings, J. L., Tariot, P. N., Aisen, P. S., et al. (2019) · Alzheimer's Research & Therapy
Alzheimer's disease research and treatmentsDementia and Cognitive Impairment Research
Cited by 81
Go further with a free account
Verify every reference, keep papers in a library, and ask questions across them.
Sign up - it is free